Most Recent

image: Special Review for H5N1 Grants?

Special Review for H5N1 Grants?

By | December 4, 2012

The National Institutes of Health reveals a controversial plan to regulate the funding of H5N1 research.

0 Comments

image: Stem Cells from Blood

Stem Cells from Blood

By | December 3, 2012

Researchers develop a practical technique for deriving stem cells from routine blood samples.  

0 Comments

image: An Epi Phenomenon

An Epi Phenomenon

By | December 1, 2012

While exploring the genetics of a rare type of tumor, Stephen Baylin discovered an epigenetic modification that occurs in most every cancer—a finding he’s helping bring to the clinic.

5 Comments

image: Contributors

Contributors

By | December 1, 2012

Meet some of the people featured in the December 2012 issue of The Scientist.

0 Comments

image: In the Long Run

In the Long Run

By | December 1, 2012

Can emulating our early human ancestors make us healthier?

1 Comment

image: Neil Bence: Manipulating Degradation

Neil Bence: Manipulating Degradation

By | December 1, 2012

Senior Scientist, Millennium Pharmaceuticals: The Takeda Oncology Company Age: 39

0 Comments

image: Waking Cancer Cells

Waking Cancer Cells

By | December 1, 2012

A protein called Coco rouses dormant breast cancer cells in the lung.

0 Comments

image: Can Worms Alleviate Autism?

Can Worms Alleviate Autism?

By | November 27, 2012

Autism researchers are testing the ability of whipworm eggs to treat autism in a new clinical trial.

10 Comments

image: Architecture Reveals Genome’s Secrets

Architecture Reveals Genome’s Secrets

By | November 25, 2012

Three-dimensional genome maps are leading to a deeper understanding of how the genome’s form influences its function.

4 Comments

image: Nose Cells Help Paralyzed Dogs

Nose Cells Help Paralyzed Dogs

By | November 20, 2012

A transplant of cells from the lining of the nose helps dogs with spinal injuries walk again.

1 Comment

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS